Attovia Therapeutics(ATTO)
SAN CARLOS, CABiotechnology
Focus: Attovia Therapeutics is a public-stage biotechnology company leveraging a proprietary biparatopic nanobody platform focused on immunology. The company is early-stage with two Phase 1 programs in atopic dermatitis.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Attovia Therapeutics?
AI assessmentHigh-risk, early-stage opportunity best suited for researchers betting on platform technology rather than career stability or near-term impact.
Why Work Here
- Join a public biotech with validated platform technology (biparatopic nanobodies) in immunology, an attractive therapeutic area
- Early-stage pipeline offers opportunity to shape drug development from Phase 1, with direct impact on program strategy
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ATTO-1310
Atopic DermatitisClinical Trials (1)
NCT06787586Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus
Phase 1Help build intelligence for Attovia Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.